Gianna Kuhles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gianna Kuhles has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Georg G. von Polier
Institute of Neuroscience and Medicine, Brain & Behaviour (INM-7), Research Centre Jülich, Jülich, Germany
2 shared publications - Juergen Dukart
Institute of Neuroscience and Medicine, Brain & Behaviour (INM-7), Research Centre Jülich, Jülich, Germany
2 shared publications - Kerstin Konrad
Institute of Medical Psychology and Medical Sociology, Faculty of Medicine, RWTH Aachen University, Aachen, Germany
2 shared publications - Leon David Lotter
Institute of Neuroscience and Medicine, Brain & Behaviour (INM-7), Research Centre Jülich, Jülich, Germany
2 shared publications - Michael Fuchs
Section of Phoniatrics and Audiology, Department of Otorhinolaryngology, University Hospital Leipzig, Leipzig, Germany
2 shared publications Michael Siniatchkin
Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, University Hospital RWTH Aachen, Aachen, Germany
2 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Springer Nature in European Child & Adolescent Psychiatry
- p. 1-13
Voice features in paediatric ADHD: baseline group differences and longitudinal change under methylphenidate
Diagnosis and treatment monitoring of attention-deficit/hyperactivity disorder (ADHD) largely rely on subjective assessments, highlighting the need for objective markers. Voice features and speech embeddings represent promising candidates, as they may offer an objective, scalable and clinically valuable complement to current practice. Yet it remains largely unclear which features are most informative for distinguishing ADHD and monitoring treatment effects, and which speech tasks best elicit these differences. Twenty-seven children with ADHD and 27 age-matched neurotypical controls completed six speech tasks across two study visits. Children with ADHD were unmedicated at baseline and were assessed under prescribed methylphenidate treatment at follow-up, whereas controls underwent repeated assessment without intervention. Established acoustic voice features and high-dimensional speech embeddings were extracted and analysed using linear mixed models to examine baseline group differences and group-by-time interaction effects reflecting medication-associated change patterns. At baseline, children with ADHD showed a lower and more variable pitch (F0 mean, F0 variability), altered spectral properties (MFCC1/MFCC2 variability), and reduced rhythmic stability (variability of voiced-segment length) compared to controls. Group-by-time interaction effects indicated medication-associated modulation in the ADHD group, including reduced loudness variability and normalization of first formant bandwidth toward control values. Speech embeddings (Whisper but not WavLM) showed FDR-significant baseline and interaction effects. Free speech tasks, particularly picture description, yielded the most robust and consistent effects. These findings support further investigation of speech-based measures as potential digital biomarkers in ADHD, with picture description emerging as a particularly promising task for future clinical assessment protocols. Clinical trial registration: German Clinical Trials Registry, registration no. DRKS00030766, Registration Date: 12 December 2022. Available: https://drks.de/search/en/trial/DRKS00030766
- 14 October 2026
- Published by Springer Nature in European Child & Adolescent Psychiatry
- p. 1-13
Open AccessVoice features in paediatric ADHD: baseline group differences and longitudinal change under methylphenidate
Diagnosis and treatment monitoring of attention-deficit/hyperactivity disorder (ADHD) largely rely on subjective assessments, highlighting the need for objective markers. Voice features and speech embeddings represent promising candidates, as they may offer an objective, scalable and clinically valuable complement to current practice. Yet it remains largely unclear which features are most informative for distinguishing ADHD and monitoring treatment effects, and which speech tasks best elicit these differences. Twenty-seven children with ADHD and 27 age-matched neurotypical controls completed six speech tasks across two study visits. Children with ADHD were unmedicated at baseline and were assessed under prescribed methylphenidate treatment at follow-up, whereas controls underwent repeated assessment without intervention. Established acoustic voice features and high-dimensional speech embeddings were extracted and analysed using linear mixed models to examine baseline group differences and group-by-time interaction effects reflecting medication-associated change patterns. At baseline, children with ADHD showed a lower and more variable pitch (F0 mean, F0 variability), altered spectral properties (MFCC1/MFCC2 variability), and reduced rhythmic stability (variability of voiced-segment length) compared to controls. Group-by-time interaction effects indicated medication-associated modulation in the ADHD group, including reduced loudness variability and normalization of first formant bandwidth toward control values. Speech embeddings (Whisper but not WavLM) showed FDR-significant baseline and interaction effects. Free speech tasks, particularly picture description, yielded the most robust and consistent effects. These findings support further investigation of speech-based measures as potential digital biomarkers in ADHD, with picture description emerging as a particularly promising task for future clinical assessment protocols. Clinical trial registration: German Clinical Trials Registry, registration no. DRKS00030766, Registration Date: 12 December 2022. Available: https://drks.de/search/en/trial/DRKS00030766
- Open Access
Speech-Based Markers in Paediatric ADHD: A Longitudinal Case-Control Study of Voice Features and Medication Effects
Background: Diagnosis and treatment monitoring of attention-deficit/hyperactivity disorder (ADHD) largely rely on subjective assessments, highlighting the need for objective markers. Voice features and speech embeddings represent promising candidates for such markers, as they may capture alterations in speech production relevant to ADHD. However, it remains unclear which speech features are most informative for distinguishing ADHD and monitoring treatment effects, and which speech tasks most reliably elicit such differences. Methods: Twenty-seven children with ADHD and 27 age-matched neurotypical controls completed six speech tasks across two study visits. Children with ADHD were unmedicated at baseline (first visit) and were assessed under prescribed methylphenidate treatment at follow-up, whereas controls underwent repeated assessment without intervention. Established acoustic voice features (eGeMAPS) and high-dimensional speech embeddings (WavLm, Whisper) were extracted and analysed using linear mixed models to examine baseline group differences and group-by-time interaction effects reflecting medication-associated change patterns. Results: At baseline, children with ADHD differed significantly from controls in frequency, spectral, and temporal voice features, characterized by lower and more variable pitch, altered spectral properties, and reduced rhythmic stability. Group-by-time interaction effects indicated medication-associated modulation in the ADHD group, including reduced loudness variability and increased precision of vowel articulation at follow-up, changes not observed in controls. Speech embeddings revealed additional baseline and interaction effects beyond established acoustic features. Free speech tasks, particularly picture description, yielded the most robust and consistent effects. Conclusion: Children with ADHD differed from neurotypical controls in vocal features at baseline and showed distinct longitudinal change patterns consistent with medication-related change. These findings support further investigation of speech-based measures as candidate digital phenotypes and potential digital biomarkers in ADHD, with picture description emerging as a particularly promising task for future clinical assessment protocols.
Open AccessSpeech-Based Markers in Paediatric ADHD: A Longitudinal Case-Control Study of Voice Features and Medication Effects
Background: Diagnosis and treatment monitoring of attention-deficit/hyperactivity disorder (ADHD) largely rely on subjective assessments, highlighting the need for objective markers. Voice features and speech embeddings represent promising candidates for such markers, as they may capture alterations in speech production relevant to ADHD. However, it remains unclear which speech features are most informative for distinguishing ADHD and monitoring treatment effects, and which speech tasks most reliably elicit such differences. Methods: Twenty-seven children with ADHD and 27 age-matched neurotypical controls completed six speech tasks across two study visits. Children with ADHD were unmedicated at baseline (first visit) and were assessed under prescribed methylphenidate treatment at follow-up, whereas controls underwent repeated assessment without intervention. Established acoustic voice features (eGeMAPS) and high-dimensional speech embeddings (WavLm, Whisper) were extracted and analysed using linear mixed models to examine baseline group differences and group-by-time interaction effects reflecting medication-associated change patterns. Results: At baseline, children with ADHD differed significantly from controls in frequency, spectral, and temporal voice features, characterized by lower and more variable pitch, altered spectral properties, and reduced rhythmic stability. Group-by-time interaction effects indicated medication-associated modulation in the ADHD group, including reduced loudness variability and increased precision of vowel articulation at follow-up, changes not observed in controls. Speech embeddings revealed additional baseline and interaction effects beyond established acoustic features. Free speech tasks, particularly picture description, yielded the most robust and consistent effects. Conclusion: Children with ADHD differed from neurotypical controls in vocal features at baseline and showed distinct longitudinal change patterns consistent with medication-related change. These findings support further investigation of speech-based measures as candidate digital phenotypes and potential digital biomarkers in ADHD, with picture description emerging as a particularly promising task for future clinical assessment protocols.